Reversely, the complementation of miR-125 leads to the decreases in STAT3, MMP-9, MMP-2, and N-cadherin levels and activities, subsequently diminishing the proliferation, metastasis, and inflammation of cervical cancer cells [146]. The gene discussed is STAT3; the disease is cervical cancer.